Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Charles River Laboratories logoCharles River Laboratories CRL

Charles River said it entered into the Tenth Amended and Restated Credit Agreement on December 13, 2024, amending and restating its existing credit agreement with JPMorgan Chase Bank, N.A. as administrative agent.

8-KCreation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Charles River said it entered into the Tenth Amended and Restated Credit Agreement on December 13, 2024, amending and restating its existing credit agreement with JPMorgan Chase Bank, N.A. as administrative agent.

  2. The company said the agreement reduces aggregate revolving commitments from $3 billion to $2 billion, extends the facility maturities and adds Charles River Laboratories, Inc. as a borrower.

  3. The company said the revolving credit facility provides for up to approximately $2 billion and matures on December 13, 2029, with no scheduled payments required before that date. It added that loans in U.S. dollars, euros and sterling bear interest at benchmark rates plus a margin based on the leverage ratio.

  4. The company said the obligations under the agreement are guaranteed by Charles River Laboratories, Inc. and secured by substantially all assets of the company and its material U.S. subsidiaries, including a pledge of 100% of the capital stock of Charles River Laboratories, Inc. and 65% of the capital stock of certain foreign subsidiaries. It also said the agreement requires compliance with an interest coverage ratio and a leverage ratio.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Tenth Amended and Restated Credit Agreement Signed

Charles River said it entered into the Tenth Amended and Restated Credit Agreement on December 13, 2024, amending and restating its existing credit agreement with JPMorgan Chase Bank, N.A. as administrative agent.

Source · Based on the filing body and exhibits

Aggregate Revolving Commitments Cut from $3 billion to $2 billion

The company said the agreement reduces aggregate revolving commitments from $3 billion to $2 billion, extends the facility maturities and adds Charles River Laboratories, Inc. as a borrower.

Source · Based on the filing body and exhibits

Revolving Facility Matures December 13, 2029; Currency and Rate Terms

The company said the revolving credit facility provides for up to approximately $2 billion and matures on December 13, 2029, with no scheduled payments required before that date. It added that loans in U.S. dollars, euros and sterling bear interest at benchmark rates plus a margin based on the leverage ratio.

Source · Based on the filing body and exhibits

Collateral, Guarantees and Financial Covenants

The company said the obligations under the agreement are guaranteed by Charles River Laboratories, Inc. and secured by substantially all assets of the company and its material U.S. subsidiaries, including a pledge of 100% of the capital stock of Charles River Laboratories, Inc. and 65% of the capital stock of certain foreign subsidiaries. It also said the agreement requires compliance with an interest coverage ratio and a leverage ratio.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.